✦ LIBER ✦

PMS23 ECONOMICAL EVALUATION OF ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS

✍ Scribed by PA Vorobyev; MV Lesnicheva; MV Avksentyeva; YI Alekseyeva; DY Karateyev

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAR8 HEALTH ECONOMIC EVALUATION OF PATIE

✍ N Vanoverbeke; L Annemans; P Cauchie; E Hendrickx 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PMS30 Pharmacoeconomic Evaluation of Toc

✍ F. Navarro sarabia; F.J. Blanco; J. Álvaro-Gracia; J. García Meijide; J. Poveda; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS46 Economic Evaluation of Adalimumab

✍ A. Benedict; T. Kongnakorn; J.W. Shaw; A. Marcellusi; D.J. Vanness; L. Gitto; P. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Adalimumab-induced neutropenia in a pati

✍ Sébastien Ottaviani; Isabelle Cerf-Payrastre; Farid Kemiche; Edouard Pertuiset 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Immune effects of therapy with Adalimuma

✍ M. Vigna-Pérez; C. Abud-Mendoza; H. Portillo-Salazar; B. Alvarado-Sánchez; E. Cu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

PMS17 THE ECONOMIC IMPLICATIONS OF ACHIE

✍ MJ Taylor; P Conway; M Lebmeier; R Batta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB